STAT3 and lung carcinoma: Some studies suggest OSM may repress lung cancer growth (171), but can promote lung cancer metastasis via activation of STAT3 and STAT5, thus increasing expression of tumorigenic factors such as tissue type plasminogen activator (tPA) (172, 173).